Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P240003/S004

Minima Stent System

Renata Medical, Inc. · Decision date Sep 11, 2025

FDA DECISIONP240003/S004

What did the FDA approve?

FDA records P240003/S004 as a supplement to PMA P240003, with the supplement type “Special (Immediate Track)”. The recorded decision is approval, dated Sep 11, 2025.

FDA approval order statement

Approval for updates to the Instructions for Use labeling, including additional precautions, intended to enhance the safe use of the Minima Stent System.
Regulatory pathway
PMA supplement
Supplement type
Special (Immediate Track)
Clinical specialty
Cardiovascular
Decision date
Sep 11, 2025
FDA change category
Labeling Change - Indications/instructions/shelf life/tradename

FDA source record

Regulatory record facts

Identifier
P240003/S004
Regulatory pathway
PMA supplement
Product code
PNF
Decision code
APPR
Decision date
Sep 11, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Aortic stent.

Product code
PNF
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P240003/S004 received

    Application receipt date recorded by FDA.

  2. P240003/S004 · FDA decision

    Special (Immediate Track)

  3. P240003/S006 · Related supplement

    Minima Pro Stent System

  4. P240003/S008 · Related supplement

    Minima Stent System; Minima Pro Stent System

Timeline entries are records held by MedtechLedger for P240003. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240003

Product / regulatory recordCompanyPathwayDecision dateSource
Renata Medical, Inc.PMA supplementDec 18, 2025FDA
Renata Medical, Inc.PMA supplementFeb 11, 2026FDA
Renata Medical, Inc.PMA supplementJul 9, 2026FDA
Renata Medical, Inc.PMA supplementAug 27, 2026FDA

Explore the linked device profile

Other records with product code PNF

Product / regulatory recordCompanyPathwayDecision dateSource
NuMED, Inc.PMA supplementJul 6, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Renata Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
4695 Macarthur Ct., Suite 1150, Newport Beach, CA, 92660

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records